Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Stylianou

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Occupational Medicine (Oxford, England)|February 4, 2020
Skin bioengineering in the diagnosis of occupational protein contact dermatitisJ H Alfonso, A K Afanou, J-Ø Holm, et al.
Contributions to Nephrology|January 1, 1990
The interaction of organism, phagocyte and mesothelial cellE Stylianou, R Mackenzie, M Davies, et al.
The Biochemical Journal|April 1, 1995
Interleukin 1-induced phosphorylation of MAD3, the major inhibitor of nuclear factor kappa B of HeLa cells. Interference in signalling by the proteinase inhibitors 3,4-dichloroisocoumarin and tosylphenylalanyl chloromethylketoneF Guesdon, T Ikebe, E Stylianou, et al.
Kidney International|June 1, 1990
Isolation, culture and characterization of human peritoneal mesothelial cellsE Stylianou, L A Jenner, M Davies, et al.
The Journal of Biological Chemistry|August 5, 1992
Interleukin 1 induces NF-kappa B through its type I but not its type II receptor in lymphocytesE Stylianou, L A O'Neill, L Rawlinson, et al.
The American Journal of Pathology|February 1, 1995
Source of peritoneal proteoglycans. Human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfate proteoglycansS Yung, G J Thomas, E Stylianou, et al.
Contributions to Nephrology|January 1, 1990
Proteoglycans of CAPD-dialysate fluid and mesotheliumM Davies, E Stylianou, S Yung, et al.
Clinical and Experimental Immunology|June 5, 2003
Raised serum levels of interleukin-18 is associated with disease progression and may contribute to virological treatment failure in HIV-1-infected patientsE Stylianou, V Bjerkeli, A Yndestad, et al.
Vaccine|October 20, 2015
Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85AE Stylianou, K L Griffiths, H C Poyntz, et al.
Clinical and Experimental Immunology|October 23, 2002
Effects of interferon-alpha on gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV-infected patientsE Stylianou, A Yndestad, L I Sikkeland, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Occupational Medicine (Oxford, England)|February 4, 2020
Skin bioengineering in the diagnosis of occupational protein contact dermatitisJ H Alfonso, A K Afanou, J-Ø Holm, et al.
Contributions to Nephrology|January 1, 1990
The interaction of organism, phagocyte and mesothelial cellE Stylianou, R Mackenzie, M Davies, et al.
The Biochemical Journal|April 1, 1995
Interleukin 1-induced phosphorylation of MAD3, the major inhibitor of nuclear factor kappa B of HeLa cells. Interference in signalling by the proteinase inhibitors 3,4-dichloroisocoumarin and tosylphenylalanyl chloromethylketoneF Guesdon, T Ikebe, E Stylianou, et al.
Kidney International|June 1, 1990
Isolation, culture and characterization of human peritoneal mesothelial cellsE Stylianou, L A Jenner, M Davies, et al.
The Journal of Biological Chemistry|August 5, 1992
Interleukin 1 induces NF-kappa B through its type I but not its type II receptor in lymphocytesE Stylianou, L A O'Neill, L Rawlinson, et al.
The American Journal of Pathology|February 1, 1995
Source of peritoneal proteoglycans. Human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfate proteoglycansS Yung, G J Thomas, E Stylianou, et al.
Contributions to Nephrology|January 1, 1990
Proteoglycans of CAPD-dialysate fluid and mesotheliumM Davies, E Stylianou, S Yung, et al.
Clinical and Experimental Immunology|June 5, 2003
Raised serum levels of interleukin-18 is associated with disease progression and may contribute to virological treatment failure in HIV-1-infected patientsE Stylianou, V Bjerkeli, A Yndestad, et al.
Vaccine|October 20, 2015
Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85AE Stylianou, K L Griffiths, H C Poyntz, et al.
Clinical and Experimental Immunology|October 23, 2002
Effects of interferon-alpha on gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV-infected patientsE Stylianou, A Yndestad, L I Sikkeland, et al.
Pageof 3